3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Pain, Postoperative
3
Breast Neoplasms
3
Colorectal Neoplasms
2
Colonic Neoplasms
2
Chronic Pain
2
Squamous Cell Carcinoma of Head and Neck
1
Postoperative Hemorrhage
1
Pilonidal Sinus
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Carcinoma, Squamous Cell
1
Interventions
pembrolizumab
12
Cisplatin
7
Cetuximab
7
Carboplatin
7
Docetaxel
6
Blood Specimen Collection
4
Radiotherapy, Intensity-Modulated
3
Paclitaxel
3
toripalimab
2
atezolizumab
2
Radiotherapy
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Fluorouracil
2
Drug Therapy
2
tocilizumab
1
regorafenib
1
osimertinib
1
lenvatinib
1
fludarabine
1
ficlatuzumab
1
cemiplimab
1
calcipotriene
1
bintrafusp alfa protein, human
1
avelumab
1
alpha-2'-deoxythioguanosine
1
aldesleukin
1
aflibercept
1
Watchful Waiting
1
Vinorelbine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Squamous Cell
×
Lidocaine
×
Clear all
NCT06747390
2026-05-12
856397
Abramson Cancer Center at Penn Medicine
Phase 1
Recruiting
30 enrolled